Valproic acid induces transcriptional activation of human GD3 synthase (hST8Sia I) in SK-N-BE(2)-C human neuroblastoma cells
Elsevier BV - 2008
Tóm tắt
In this study, we have shown the transcriptional regulation of the human GD3 synthase (hST8Sia I) induced by valproic acid (VPA) in human neuroblastoma SK-N-BE(2)-C cells. To elucidate the mechanism underlying the regulation of hST8Sia I gene expression in VPA-stimulated SK-N-BE(2)-C cells, we characterized the promoter region of the hST8Sia I gene. Functional analysis of the 5′-flanking region of the hST8Sia I gene by the transient expression method showed that the −1146 to −646 region, which contains putative binding sites for transcription factors c-Ets-1, CREB, AP-1 and NF-κB, functions as the VPA-inducible promoter of hST8Sia I in SK-N-BE(2)-C cells. Site-directed mutagenesis and electrophoretic mobility shift assay indicated that the NF-κB binding site at −731 to −722 was crucial for the VPA-induced expression of hST8Sia I in SK-N-BE(2)-C cells. In addition, the transcriptional activity of hST8Sia I induced by VPA in SK-N-BE(2)-C cells was strongly inhibited by SP600125, which is a c-Jun N-terminal kinase (JNK) inhibitor, and GÖ6976, which is a protein kinase C (PKC) inhibitor, as determined by RT-PCR (reverse transcription-polymerase chain reaction) and luciferase assays. These results suggest that VPA markedly modulated transcriptional regulation of hST8Sia I gene expression through PKC/JNK signal pathways in SK-N-BE(2)-C cells.
Từ khóa
Tài liệu tham khảo
Beecken, W.D., Engl, T., Ogbomo, H., Relja, B., Cinatl, J., Bereiter-Hahn, J., Oppermann, E., Jonas, D., and Blaheta, R.A. (2005). Valproic acid modulates NCAM polysialylation and polysialyl-transferase mRNA expression in human tumor cells. Int. Im-munopharmacol. 5, 757–769.
Blaheta, R.A., Michaelis, M., Driever, P.H., and Cinatl, J. Jr. (2005). Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies. Med. Res. Rev. 25, 383–397.
Chen, G., Yuan, P.X., Jiang, Y.M., Huang, L.D., and Manji, H.K. (1999). Valproate robustly enhances AP-1 mediated gene expression. Mol. Brain Res. 64, 52–58.
Chen, F., Castranova, V., and Shi, X. (2001). New insights into the role of nuclear factor-κB in cell growth regulation. Am. J. Pathol. 159, 387–397.
Cheung, N.K., Saarinen, U.M., Neely, J.E., Landmeier, B., Donovan, D., and Coccia, P.F. (1985). Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res. 45, 2642–2649.
Cinatl, J.Jr., Cinatl, J., Scholz, M., Driever, P.H., Henrich, D., Kabickova, H., Vogel, J.U., Doerr, H.W., and Kornhuber, B. (1996). Antitumor activity of sodium valproate in cultures of human neuroblastoma cells. Anticancer Drugs 7, 766–773.
Cinatl, J.Jr., Cinatl, J., Driever, P.H., Kotchetkov, R., Pouckova, P., Kornhuber, B., and Schwabe, D. (1997). Sodium valproate inhibits in vivo growth of human neuroblastoma cells. Anticancer Drugs 8, 958–963.
Cinatl, J.Jr., Kotchetkov, R., Blaheta, R., Driever, P.H., Vogel, J.U., and Cinatl, J. (2002). Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-α. Int. J. Oncol. 20, 97–106.
Ghosh, S., and Karin, M. (2002). Missing pieces in the NF-κB puzzle. Cell 109, S81–S96.
Gottlicher, M., Minucci, S., Zhu, P., Kramer, O.H., Schimpf, A., Giavara, S., Sleeman, J.P., Lo Coco, F., Nervi, C., Pelicci, P.G., et al. (2001). Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20, 6969–6978.
Gratsa, A., Rooprai, H.K., Rogers, J.P., Martin, K.K., and Pilkington, G.J. (1997). Correlation of expression of NCAM and GD3 gan-glioside to motile behavior in neoplastic glia. Anticancer Res. 17, 4111–4118.
Gurvich, N., Tsygankova, O.M., Meinkoth, J.L., and Klein, P.S. (2004). Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res. 64, 1079–1086.
Hakomori, S. (1981). Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu. Rev. Biochem. 50, 733–764.
Hakomori, S., and Igarashi, Y. (1993). Gangliosides and glycosphingolipids as modulators of cell growth, adhesion, and transmembrane signaling. Adv. Lipid Res. 25, 147–162.
Johannessen, C.U. (2000). Mechanisms of action of valproate: a commentatory. Neurochem. Int. 37, 103–110.
Kang, N.Y., Kang, S.K., Lee, Y.C., Choi, H.J., Lee, Y.S., Cho, S.Y., Kim, Y.S., Ko, J.H., and Kim, C.H. (2006). Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-κB in regulated expression. Glycobiology 16, 375–389.
Kang, N.Y., Kim, C.H., Kim, K.S., Ko, J.H., Lee, J.H., Jeong, Y.K., and Lee, Y.C. (2007). Expression of the human CMP-NeuAc: GM3 alpha2,8-sialyltransferase (GD3 synthase) gene through the NF-κB activation in human melanoma SK-MEL-2 cells. Bio-chim. Biophys. Acta 1769, 622–630.
Phiel, C.J., Zhang, F., Huang, E.Y., Guenther, M.G., Lazar, M.A., and Klein, P.S. (2001). Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734–36741.
Rogawski, M.A., and Loscher, W. (2004). The neurobiology of antiepileptic drugs. Nat. Rev. Neurosci. 5, 553–564.
Stockhausen, M.T., Sjölund, J., Manetopoulos, C., and Axelson, H. (2005). Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells. Br. J. Cancer 92, 751–759.
Svennerholm, L. (1980). Gangliosides and synaptic transmission. Adv. Exp. Med. Biol. 125, 533–544.
Varki, A. (1993). Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3, 97–130.
Yuan, P.X., Huang, L.D., Jiang, Y.M., Gutkind, J.S., Manji, H.K., and Chen, G. (2001). The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J. Biol. Chem. 276, 31674–31683.